|
|||||
|
|
Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes |
|
| Authors: | Garber A J,Larsen J,Schneider S H,Piper B A,Henry D Glyburide/Metformin Initial Therapy Study Group |
| Affiliation: | Baylor College of Medicine and The Methodist Hospital, Houston, Texas, USA;University of Nebraska Medical Center-DEM, Omaha, Nebraska, USA;Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA;Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey, USA |
| Abstract: | |
| Keywords: | type 2 diabetes glyburide metformin glycaemic control combination glyburide metformin therapy/glibenclamide |
| 本文献已被 PubMed 等数据库收录！ | |